### ğŸ« Pulmonary Medicine: Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)

#### âœ… True Statements
1. **Amyotrophic lateral sclerosis (ALS)** is marked by **chronic hypoventilation during sleep**, which may be exacerbated by **acute illness** and **anesthesia**.
2. **Bilevel positive airway pressure (BPAP)** augments ventilation by providing **pressure support**, improves **quality of life**, and may **prolong survival** in patients with **ALS**.
3. **Ventilatory support** should be started in **ALS** when **respiratory symptoms** or **hypercapnia** are present.
4. **Continuous positive airway pressure (CPAP)** maintains **upper airway patency** in **obstructive sleep apnea (OSA)** and is not appropriate ventilatory support for **ALS-related hypoventilation**.
5. **Hypoglossal nerve stimulation** activates the tongue muscles to increase **upper airway caliber** and is used for **OSA**, but has no effect on **respiratory pump muscles weakened by ALS**.
6. **Supplemental oxygen** should not be prescribed for patients with **ALS and hypoventilation** without **ventilatory support**, because it may worsen **hypercapnia** in the setting of **respiratory muscle weakness**.

#### ğŸ’¬ Extra
1. Elevated arterial **Pcoâ‚‚** with metabolic alkalosis but normal pH indicates **chronic hypoventilation**.
2. Discussing **prognosis** and establishing **goals of care** with patients and families is essential to avoid unnecessary interventions.

#### ğŸ·ï¸ Tags
#PulmonaryMedicine #ALS #NoninvasiveVentilation #BPAP #Hypercapnia #AmbulatoryCare

#### ğŸ“š Reference
Khan A, Frazer-Green L, Amin R, et al. Respiratory management of patients with neuromuscular weakness: an American College of Chest Physicians clinical practice guideline and expert panel report. *Chest*. 2023;164:394-413. PMID: 36921894 doi:10.1016/j.chest.2023.03.011

#### ğŸ†” Question ID
PMQQQ24013

#### ğŸ•’ Last Updated
February 2025

---

#### ğŸ“– Related Text
MKSAP 19: Pulmonary Medicine â€” Sleep Medicine, Sleep-Related Hypoventilation Syndromes, Neuromuscular Diseases

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Noninvasive positive-pressure ventilation devices** are prescribed to alleviate **sleep-related symptoms** and support **oxygen levels** in patients with **neuromuscular disorders**.
2. **BPAP** or **volume-assured devices** (such as **average volume-assured pressure support**) with or without **supplemental oxygen** are indicated when **daytime hypercapnia** suggests **chronic respiratory failure**.
3. **Polysomnography** may be useful for optimizing **ventilator and oxygen settings** and for assessing **concomitant sleep disorders**, though it is **not always required**.
4. **Tracheostomy and home mechanical ventilation** are **effective** and may be appropriate for some patients with **neuromuscular disorders**.
5. **Supplemental oxygen** may **depress ventilation** in patients with **respiratory muscle weakness** and should generally **not** be prescribed without **adjunctive ventilatory support**.

#### ğŸ’¬ Extra
2. **Volumeâ€‘assured devices** target a **specific tidal volume** by adjusting **inspiratory pressure**.
3. While helpful for titration, **sleep studies** are **not mandatory** for initiating noninvasive support.

---

#### ğŸ—¾ Supplemental Tables

<table>
  <caption><strong>Characteristics and Indications of Positive Airway Pressure Modes</strong></caption>
  <thead>
    <tr>
      <th>Mode</th>
      <th>Description</th>
      <th>Indication</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>CPAP</td>
      <td>Fixed pressure derived from an in-laboratory titration attended by a technician</td>
      <td>OSA<br>Occasionally CSA</td>
    </tr>
    <tr>
      <td>APAP</td>
      <td>Range of pressure delivered to maintain upper airway patency, determined by a proprietary computer algorithm</td>
      <td>OSA</td>
    </tr>
    <tr>
      <td>BPAP</td>
      <td>Inspiratory pressure support delivered above a minimum expiratory pressure, derived from an in-laboratory titration</td>
      <td>Hypoventilation syndromes</td>
    </tr>
    <tr>
      <td>Auto-BPAP</td>
      <td>Range of bilevel pressures determined by a proprietary computer algorithm</td>
      <td>Same as BPAP</td>
    </tr>
    <tr>
      <td>ASV</td>
      <td>Breath-by-breath adjustment of inspiratory pressure support and back-up rate determined by a proprietary computer algorithm; expiratory pressure set by a technician</td>
      <td>CSA (including mixed CSA and OSA); do not use in patients with heart failure with reduced ejection fraction</td>
    </tr>
    <tr>
      <td>Auto-ASV</td>
      <td>Inspiratory and expiratory pressures determined by a proprietary algorithm</td>
      <td>Same as ASV</td>
    </tr>
  </tbody>
</table>

<p><em>
APAP = auto-adjusting positive airway pressure; ASV = adaptive servo-ventilation; BPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; CSA = central sleep apnea; OSA = obstructive sleep apnea.
</em></p>

---

### ğŸ“˜ Related Text Derivations â€” Table

#### âœ… True Statements â€” Characteristics and Indications of Positive Airway Pressure Modes
1. **Continuous positive airway pressure (CPAP)** is a **fixed pressure** modality derived from **in-laboratory titration** attended by a technician and is indicated for **obstructive sleep apnea (OSA)** and **occasionally central sleep apnea (CSA)**.
2. **Autoâ€‘adjusting positive airway pressure (APAP)** delivers a **range of pressures** to maintain **upper airway patency** based on a **proprietary computer algorithm** and is indicated for **OSA**.
3. **Bilevel positive airway pressure (BPAP)** provides **inspiratory pressure support** above a **minimum expiratory pressure** derived from **inâ€‘laboratory titration** and is indicated for **hypoventilation syndromes**.
4. **Autoâ€‘BPAP** delivers a **range of bilevel pressures** determined by a **proprietary computer algorithm** and has the **same indications as BPAP**.
5. **Adaptive servoâ€‘ventilation (ASV)** adjusts **inspiratory pressure support** and a **backâ€‘up rate** on a **breathâ€‘byâ€‘breath** basis using a **proprietary algorithm** with **expiratory pressure set by a technician**; it is indicated for **CSA (including mixed CSA and OSA)** and should **not** be used in **heart failure with reduced ejection fraction (HFrEF)**.
6. **Autoâ€‘ASV** determines both **inspiratory and expiratory pressures** via a **proprietary algorithm** and has the **same indications as ASV**.

#### ğŸ’¬ Extra
1. For CPAP, the table specifies **technicianâ€‘attended titration** as the source of the fixed pressure.
2. For APAP and Autoâ€‘BPAP, the **algorithmic determination** of pressures is emphasized rather than clinicianâ€‘set values.
5. The **doâ€‘notâ€‘use** warning with **HFrEF** is explicitly stated in the table under ASV indications.
